roundhill glp-1 & weight loss etf drug bets big on Eli Lilly, Novo Nordisk OZEM: Active Management Crucial in

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

For practices operating at scale, the metabolic health EMR workflow includes templated diabetes review sections that prompt clinicians to document all active antidiabetic agents, confirm therapy duration, and tag insulin use as ongoing rather than situational

Associations of semaglutide with first-time diagnosis of Alzheimers disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US

Notably, a recent meta-analysis of cohort studies revealed that dipeptidyl peptidase-4 inhibitors (DPP-4i) can significantly improve cognitive functions in patients with type-2 diabetes compared to other classes of glucose-lowering agents (i.e., sulfonylurea and metformin) [4]

Similar content being viewed by others Introduction Over 460 million people worldwide have diabetes [1]

Eur J Clin Pharmacol 77:18051814